Focusing on the Diabetes Patient

Published Online: Friday, November 8, 2013
Follow Pharmacy_Times:
Jonathan G. Marquess, PharmD, CDE, President and CEO of the Institute for Wellness and Education, Inc, explains why he decided to focus on caring for diabetes patients at his pharmacy. This interview was recorded at the National Community Pharmacists Association 115th Annual Convention in Orlando.

Related Articles
The FDA refused to approve Novo Nordisk’s ultra-long-acting insulin treatments 2 years ago.
The FDA has approved GlaxoSmithKline’s Tanzeum (albiglutide) subcutaneous injection as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
The FDA refused to approve the ultra-long-acting insulin treatments 2 years ago.
Diabetes mellitus diagnoses are soaring in numbers, with the elderly population disproportionately affected. The APhA featured a case-based presentation at its 2015 annual meeting in San Diego, CA, that discussed diabetes management’s complexities in older adults.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$